Trastuzumab Biosimilar Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1551465 No. of Pages: 71 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
This report aims to provide a comprehensive presentation of the global market for Trastuzumab Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Biosimilar. This report contains market size and forecasts of Trastuzumab Biosimilar in global, including the following market information:
Global Trastuzumab Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Trastuzumab Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Trastuzumab Biosimilar companies in 2022 (%)
The global Trastuzumab Biosimilar market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trastuzumab Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, by Type, 2022 (%)
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
Others
Global Trastuzumab Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Online Pharmacy
Global Trastuzumab Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Trastuzumab Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trastuzumab Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Trastuzumab Biosimilar revenues share in global market, 2022 (%)
Key companies Trastuzumab Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Trastuzumab Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
Pfizer Inc
Samsung Bioepis
Merck & Co.
Biocon Limited
Teva Pharmaceutical
Genentech
Mundipharma
Celltrion
Henlius
Outline of Major Chapters:
Chapter 1: Introduces the definition of Trastuzumab Biosimilar, market overview.
Chapter 2: Global Trastuzumab Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Trastuzumab Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Trastuzumab Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Trastuzumab Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Trastuzumab Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Trastuzumab Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Trastuzumab Biosimilar Overall Market Size
2.1 Global Trastuzumab Biosimilar Market Size: 2022 VS 2029
2.2 Global Trastuzumab Biosimilar Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Trastuzumab Biosimilar Sales: 2018-2029
3 Company Landscape
3.1 Top Trastuzumab Biosimilar Players in Global Market
3.2 Top Global Trastuzumab Biosimilar Companies Ranked by Revenue
3.3 Global Trastuzumab Biosimilar Revenue by Companies
3.4 Global Trastuzumab Biosimilar Sales by Companies
3.5 Global Trastuzumab Biosimilar Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Trastuzumab Biosimilar Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Trastuzumab Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Trastuzumab Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Trastuzumab Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Trastuzumab Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Trastuzumab Biosimilar Market Size Markets, 2022 & 2029
4.1.2 Adjuvant Breast Cancer
4.1.3 Metastatic Breast Cancer
4.1.4 Metastatic Gastric Cancer
4.1.5 Others
4.2 By Type - Global Trastuzumab Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Trastuzumab Biosimilar Revenue, 2018-2023
4.2.2 By Type - Global Trastuzumab Biosimilar Revenue, 2024-2029
4.2.3 By Type - Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
4.3 By Type - Global Trastuzumab Biosimilar Sales & Forecasts
4.3.1 By Type - Global Trastuzumab Biosimilar Sales, 2018-2023
4.3.2 By Type - Global Trastuzumab Biosimilar Sales, 2024-2029
4.3.3 By Type - Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
4.4 By Type - Global Trastuzumab Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Trastuzumab Biosimilar Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.2 By Application - Global Trastuzumab Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Trastuzumab Biosimilar Revenue, 2018-2023
5.2.2 By Application - Global Trastuzumab Biosimilar Revenue, 2024-2029
5.2.3 By Application - Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
5.3 By Application - Global Trastuzumab Biosimilar Sales & Forecasts
5.3.1 By Application - Global Trastuzumab Biosimilar Sales, 2018-2023
5.3.2 By Application - Global Trastuzumab Biosimilar Sales, 2024-2029
5.3.3 By Application - Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
5.4 By Application - Global Trastuzumab Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Trastuzumab Biosimilar Market Size, 2022 & 2029
6.2 By Region - Global Trastuzumab Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Trastuzumab Biosimilar Revenue, 2018-2023
6.2.2 By Region - Global Trastuzumab Biosimilar Revenue, 2024-2029
6.2.3 By Region - Global Trastuzumab Biosimilar Revenue Market Share, 2018-2029
6.3 By Region - Global Trastuzumab Biosimilar Sales & Forecasts
6.3.1 By Region - Global Trastuzumab Biosimilar Sales, 2018-2023
6.3.2 By Region - Global Trastuzumab Biosimilar Sales, 2024-2029
6.3.3 By Region - Global Trastuzumab Biosimilar Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Trastuzumab Biosimilar Revenue, 2018-2029
6.4.2 By Country - North America Trastuzumab Biosimilar Sales, 2018-2029
6.4.3 US Trastuzumab Biosimilar Market Size, 2018-2029
6.4.4 Canada Trastuzumab Biosimilar Market Size, 2018-2029
6.4.5 Mexico Trastuzumab Biosimilar Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Trastuzumab Biosimilar Revenue, 2018-2029
6.5.2 By Country - Europe Trastuzumab Biosimilar Sales, 2018-2029
6.5.3 Germany Trastuzumab Biosimilar Market Size, 2018-2029
6.5.4 France Trastuzumab Biosimilar Market Size, 2018-2029
6.5.5 U.K. Trastuzumab Biosimilar Market Size, 2018-2029
6.5.6 Italy Trastuzumab Biosimilar Market Size, 2018-2029
6.5.7 Russia Trastuzumab Biosimilar Market Size, 2018-2029
6.5.8 Nordic Countries Trastuzumab Biosimilar Market Size, 2018-2029
6.5.9 Benelux Trastuzumab Biosimilar Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Trastuzumab Biosimilar Revenue, 2018-2029
6.6.2 By Region - Asia Trastuzumab Biosimilar Sales, 2018-2029
6.6.3 China Trastuzumab Biosimilar Market Size, 2018-2029
6.6.4 Japan Trastuzumab Biosimilar Market Size, 2018-2029
6.6.5 South Korea Trastuzumab Biosimilar Market Size, 2018-2029
6.6.6 Southeast Asia Trastuzumab Biosimilar Market Size, 2018-2029
6.6.7 India Trastuzumab Biosimilar Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Trastuzumab Biosimilar Revenue, 2018-2029
6.7.2 By Country - South America Trastuzumab Biosimilar Sales, 2018-2029
6.7.3 Brazil Trastuzumab Biosimilar Market Size, 2018-2029
6.7.4 Argentina Trastuzumab Biosimilar Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Trastuzumab Biosimilar Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Trastuzumab Biosimilar Sales, 2018-2029
6.8.3 Turkey Trastuzumab Biosimilar Market Size, 2018-2029
6.8.4 Israel Trastuzumab Biosimilar Market Size, 2018-2029
6.8.5 Saudi Arabia Trastuzumab Biosimilar Market Size, 2018-2029
6.8.6 UAE Trastuzumab Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Trastuzumab Biosimilar Major Product Offerings
7.1.4 Amgen Inc. Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 Pfizer Inc
7.2.1 Pfizer Inc Company Summary
7.2.2 Pfizer Inc Business Overview
7.2.3 Pfizer Inc Trastuzumab Biosimilar Major Product Offerings
7.2.4 Pfizer Inc Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Inc Key News & Latest Developments
7.3 Samsung Bioepis
7.3.1 Samsung Bioepis Company Summary
7.3.2 Samsung Bioepis Business Overview
7.3.3 Samsung Bioepis Trastuzumab Biosimilar Major Product Offerings
7.3.4 Samsung Bioepis Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.3.5 Samsung Bioepis Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Trastuzumab Biosimilar Major Product Offerings
7.4.4 Merck & Co. Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Biocon Limited
7.5.1 Biocon Limited Company Summary
7.5.2 Biocon Limited Business Overview
7.5.3 Biocon Limited Trastuzumab Biosimilar Major Product Offerings
7.5.4 Biocon Limited Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.5.5 Biocon Limited Key News & Latest Developments
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Company Summary
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Major Product Offerings
7.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.6.5 Teva Pharmaceutical Key News & Latest Developments
7.7 Genentech
7.7.1 Genentech Company Summary
7.7.2 Genentech Business Overview
7.7.3 Genentech Trastuzumab Biosimilar Major Product Offerings
7.7.4 Genentech Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.7.5 Genentech Key News & Latest Developments
7.8 Mundipharma
7.8.1 Mundipharma Company Summary
7.8.2 Mundipharma Business Overview
7.8.3 Mundipharma Trastuzumab Biosimilar Major Product Offerings
7.8.4 Mundipharma Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.8.5 Mundipharma Key News & Latest Developments
7.9 Celltrion
7.9.1 Celltrion Company Summary
7.9.2 Celltrion Business Overview
7.9.3 Celltrion Trastuzumab Biosimilar Major Product Offerings
7.9.4 Celltrion Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.9.5 Celltrion Key News & Latest Developments
7.10 Henlius
7.10.1 Henlius Company Summary
7.10.2 Henlius Business Overview
7.10.3 Henlius Trastuzumab Biosimilar Major Product Offerings
7.10.4 Henlius Trastuzumab Biosimilar Sales and Revenue in Global (2018-2023)
7.10.5 Henlius Key News & Latest Developments
8 Global Trastuzumab Biosimilar Production Capacity, Analysis
8.1 Global Trastuzumab Biosimilar Production Capacity, 2018-2029
8.2 Trastuzumab Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Trastuzumab Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Trastuzumab Biosimilar Supply Chain Analysis
10.1 Trastuzumab Biosimilar Industry Value Chain
10.2 Trastuzumab Biosimilar Upstream Market
10.3 Trastuzumab Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Trastuzumab Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com